Clinical manifestations of blood cell parameters and inflammatory factors in 92 patients with COVID-19
Rongrong Deng(Unknown), Chengbin Li(Yunnan University), Zhongxiao Fu(University of Virginia), Weiyang Fu(Jingzhou Central Hospital), Huan Qi(Qingdao Institute of Bioenergy and Bioprocess Technology), Liyao Gou(Mindray (China)), Jianping Xiao(Dalian Institute of Chemical Physics), Xiaomei Zhang(The University of Sydney), Tao Li(Yangtze University), Changzheng Wang(Yangtze University), Yi Ye(Sun Yat-sen University), Bo Ye(Fudan University), Feng Shao(Nantong University)
Cited by 5
Related Papers
SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70
|Cellular and Molecular Immunology|2020|376
Accelerating electrochemical CO2 reduction to multi-carbon products via asymmetric intermediate binding at confined nanointerfaces
|Nature Communications|2023|329
Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients
|Cell Reports|2021|183
Phagemid Vectors for Phage Display: Properties, Characteristics and Construction
|Journal of Molecular Biology|2012|145
Antibody dynamics to SARS‐CoV‐2 in asymptomatic COVID‐19 infections
|Allergy|2020|138